Abstract
Recent-onset psychosis often has a suboptimal therapeutic outcome as a result of early treatment discontinuation and poor adherence to treatment. These patients will gain the most by attaining remission and have the most to lose through relapse (eg, in terms of education or employment). Long-acting injectable antipsychotic (LAI) drug use addresses the issue of and ensures adherence. The aim of our study was to review the existing literature on LAI drug use in recent-onset psychosis to meta-analyze the results and to find whether early treatment in terms of illness duration and age affect the outcome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
